Journal article · 2012 · Open access
Big Pharma, little science?
Technological Forecasting and Social Change, 81, 22–38 · Published 24 July 2012 · DOI 10.1016/j.techfore.2012.06.007
In brief
“Big Pharma, little science?” is a 2012 journal article by Ismael Ràfols and 6 co-authors, published in Technological Forecasting and Social Change. OpenAlex counts 150 citations as of 22 November 2026, which puts it in the top 3% of works published in 2012 by citations. It is open access under a public domain licence: the full text is free to read at Technological Forecasting and Social Change.
- Citations
- 150
- Most cited in
- 2023 (17)
- Field-weighted impact
- 16.61
- References
- 79
- Authors
- 7
Abstract
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characterised by stagnation in the numbers of new drug approvals in the face of increasing R&D costs. This study explores pharmaceutical R&D dynamics by examining the publication activities of all R&D laboratories of the major European and US pharmaceutical firms (Big Pharma) during the period 1995–2009. The empirical findings present an industry in transformation. In the first place, we observe a decline of the total number of publications by large firms. Second, we show a relative increase of their external collaborations suggesting a tendency to outsource, and a diversification of the disciplinary base, in particular towards computation, health services and more clinical approaches. Also evident is a more pronounced decline in publications by both R&D laboratories located in Europe and by firms with European headquarters. Finally, while publications by Big Pharma in emerging economies sharply increase, they remain extremely low compared with those in developed countries. In summary, the trend in this transformation is one of a gradual decrease in internal research efforts and increasing reliance on external research. These empirical insights support the view that Big Pharma are increasingly becoming ‘network integrators’ rather than the prime locus of drug discovery.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ràfols, I., Hopkins, M. M., Hoekman, J., Siepel, J., O’Hare, A., Perianes‐Rodríguez, A., & Nightingale, P. (2012). Big Pharma, little science? Technological Forecasting and Social Change, 81, 22–38. https://doi.org/10.1016/j.techfore.2012.06.007
MLA 9
Ràfols, Ismael, et al. “Big Pharma, little science?” Technological Forecasting and Social Change, vol. 81, 2012, pp. 22–38. https://doi.org/10.1016/j.techfore.2012.06.007.
Chicago
Ràfols, Ismael, Michael M. Hopkins, Jarno Hoekman, Josh Siepel, Alice O’Hare, Antonio Perianes‐Rodríguez, and Paul Nightingale. 2012. “Big Pharma, little science?” Technological Forecasting and Social Change 81: 22–38. https://doi.org/10.1016/j.techfore.2012.06.007.
Harvard
Ràfols, I. et al. (2012) ‘Big Pharma, little science?’, Technological Forecasting and Social Change, 81, pp. 22–38. doi:10.1016/j.techfore.2012.06.007.
IEEE
I. Ràfols et al., “Big Pharma, little science?,” Technological Forecasting and Social Change, vol. 81, pp. 22–38, 2012, doi: 10.1016/j.techfore.2012.06.007.
BibTeX
@article{rafols2012pharma,
title = {{Big Pharma, little science?}},
author = {Ràfols, Ismael and Hopkins, Michael M. and Hoekman, Jarno and Siepel, Josh and O’Hare, Alice and Perianes‐Rodríguez, Antonio and Nightingale, Paul},
journal = {Technological Forecasting and Social Change},
year = {2012},
volume = {81},
pages = {22--38},
doi = {10.1016/j.techfore.2012.06.007},
url = {https://doi.org/10.1016/j.techfore.2012.06.007}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 12 | |
| 2018 | 11 | |
| 2019 | 7 | |
| 2020 | 12 | |
| 2021 | 14 | |
| 2022 | 13 | |
| 2023 | 17 | |
| 2024 | 11 | |
| 2025 | 9 | |
| 2026 | 4 |
Its field-weighted citation impact is 16.61: it has been cited 16.61 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- pharmaceutical R&D
- Big Pharma
- R&D productivity
- drug discovery
- scientific publications
- external collaboration
- R&D outsourcing
- emerging markets
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Ràfols, I., Hopkins, M. M., Hoekman, J., Siepel, J., O’Hare, A., Perianes‐Rodríguez, A., & Nightingale, P. (2012). Big Pharma, little science? Technological Forecasting and Social Change, 81, 22–38. https://doi.org/10.1016/j.techfore.2012.06.007
How many times has this paper been cited?
150 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Technological Forecasting and Social Change: sign in and open the PDF from this page.
Who wrote this paper?
Ismael Ràfols, Michael M. Hopkins, Jarno Hoekman, Josh Siepel, Alice O’Hare, Antonio Perianes‐Rodríguez, Paul Nightingale.
What is the DOI of this paper?
10.1016/j.techfore.2012.06.007, permanently at https://doi.org/10.1016/j.techfore.2012.06.007. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.